RAP 0.00% 20.5¢ resapp health limited

Ann: Positive Preliminary Results from Adult Clinical Study-RAP.AX, page-289

  1. 2,547 Posts.
    lightbulb Created with Sketch. 217
    "... study showed ResApp’s algorithmic tool to be highly accurate in identifying disorders such as asthma and pneumonia — more so than the trusted stethoscope." [my emphasis]
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.